- Home
- UTF vs QDEL Comparison
UTF vs QDEL Comparison
Compare UTF & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTF
- QDEL
- Stock Information
- Founded
- UTF 2004
- QDEL 1979
- Country
- UTF United States
- QDEL United States
- Employees
- UTF N/A
- QDEL N/A
- Industry
- UTF Finance Companies
- QDEL Medical Specialities
- Sector
- UTF Finance
- QDEL Health Care
- Exchange
- UTF Nasdaq
- QDEL Nasdaq
- Market Cap
- UTF 2.3B
- QDEL 2.1B
- IPO Year
- UTF N/A
- QDEL N/A
- Fundamental
- Price
- UTF $24.04
- QDEL $30.61
- Analyst Decision
- UTF
- QDEL Hold
- Analyst Count
- UTF 0
- QDEL 6
- Target Price
- UTF N/A
- QDEL $39.00
- AVG Volume (30 Days)
- UTF 171.7K
- QDEL 1.3M
- Earning Date
- UTF 01-01-0001
- QDEL 11-05-2025
- Dividend Yield
- UTF 7.19%
- QDEL N/A
- EPS Growth
- UTF N/A
- QDEL N/A
- EPS
- UTF 2.84
- QDEL N/A
- Revenue
- UTF $138,636,669.00
- QDEL $2,741,600,000.00
- Revenue This Year
- UTF N/A
- QDEL N/A
- Revenue Next Year
- UTF N/A
- QDEL $2.65
- P/E Ratio
- UTF $9.16
- QDEL N/A
- Revenue Growth
- UTF 19.80
- QDEL N/A
- 52 Week Low
- UTF $22.05
- QDEL $22.05
- 52 Week High
- UTF $26.53
- QDEL $49.45
- Technical
- Relative Strength Index (RSI)
- UTF 41.88
- QDEL 62.32
- Support Level
- UTF $23.90
- QDEL $25.48
- Resistance Level
- UTF $24.23
- QDEL $30.85
- Average True Range (ATR)
- UTF 0.26
- QDEL 1.21
- MACD
- UTF 0.06
- QDEL 0.25
- Stochastic Oscillator
- UTF 23.73
- QDEL 98.32
About UTF Cohen & Steers Infrastructure Fund Inc
Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. It invests majority of its managed assets in securities issued by infrastructure companies, which consists of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies, under normal market conditions.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.